New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics

Systemic sclerosis (SSc) is a chronic autoimmune disease with a poor prognosis. Among the various complications of SSc, treatment options for the fibrotic lesions, skin sclerosis, and SSc-associated interstitial lung disease (SSc-ILD) have been limited. However, since 2019, the efficacy and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebata, Satoshi, Yoshizaki-Ogawa, Asako, Sato, Shinichi, Yoshizaki, Ayumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369903/
https://www.ncbi.nlm.nih.gov/pubmed/35956246
http://dx.doi.org/10.3390/jcm11154631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369903/
https://www.ncbi.nlm.nih.gov/pubmed/35956246
http://dx.doi.org/10.3390/jcm11154631

Ejemplares similares